Showing results (341-350 of 7,002) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|February 26, 2021
Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trialKeunchil Park, Mustafa Özgüroğlu, Johan Vansteenkiste, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2021
Controversies and challenges in the pathologic examination of lung resection specimens after neoadjuvant treatmentAnnikka Weissferdt, Apar Pataer, Stephen G Swisher, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2021
Clinical utility of plasma EGFR mutation detection with quantitative PCR in advanced lung cancer: A meta-analysisPeey-Sei Kok, Kirsty Lee, Sally Lord, et al.
Lung Cancer (Amsterdam, Netherlands)|May 6, 2014
The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinomaPeiou Lu, Yajuan Sun, Yanqin Sun, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2021
Surgical or medical strategy for locally-advanced, stage IIIA/B-N2 non-small cell lung cancer: Reproducibility of decision-making at a multidisciplinary tumor boardJuliette Mainguene, Clémence Basse, Philippe Girard, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2021
Antibody drug conjugates in non-small cell lung cancer: An emerging therapeutic approachS Marks, J Naidoo
Lung Cancer (Amsterdam, Netherlands)|November 14, 2021
Treatment strategies for unresectable locally advanced non-small cell lung cancer in the real-life ESME cohortNicolas Girard, Maurice Perol, Gaëtane Simon, et al.
Lung Cancer (Amsterdam, Netherlands)|November 5, 2021
Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the NetherlandsJelle Evers, Lizza E L Hendriks, Katrien De Jaeger, et al.
Lung Cancer (Amsterdam, Netherlands)|November 6, 2021
Quality of life after VATS lung resection and SABR for early-stage non-small cell lung cancer: A longitudinal studyCecilia Pompili, Zoe Rogers, Kate Absolom, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2021
The highlights of the 15th international conference of the international mesothelioma interest group - Do molecular concepts challenge the traditional approach to pathological mesothelioma diagnosis?Sonja Klebe, Francoise Galateau Salle, Rossella Bruno, et al.
Pageof 701